Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

SEBI Imposes ₹20 Lakh Penalty On 4 Entities For Non-Genuine Trading In BSE’s Stock Options...

SEBI Imposes ₹20 Lakh Penalty On 4 Entities For Non-Genuine Trading In BSE’s Stock Options...

SEBI Imposes ₹7 Lakh Penalty On Winway Research For Failing To Resolve Investor Grievances

SEBI Imposes ₹7 Lakh Penalty On Winway Research For Failing To Resolve Investor Grievances

SEBI Issues Warning To ABB India Over Alleged Insider Trading Violations

SEBI Issues Warning To ABB India Over Alleged Insider Trading Violations

Mumbai: Prestige Group Acquires Prime 22,135 Sq. Mtrs Land For Residential Development

Mumbai: Prestige Group Acquires Prime 22,135 Sq. Mtrs Land For Residential Development

BMW Unveils 2024 M340i in India with a Price Tag of Rs 74.90 Lakh

BMW Unveils 2024 M340i in India with a Price Tag of Rs 74.90 Lakh